Loading clinical trials...
Loading clinical trials...
Markers for Glycaemic Control and Continuous Glucose Monitoring in Persons With Type 2 Diabetes on Peritoneal Dialysis
Conditions
Interventions
Continuous glucose monitoring
Glycaemic markers
Locations
5
Denmark
Herlev Hospital
Copenhagen, Denmark
Rigshospitalet department of endocrinology
Copenhagen, Denmark
Hillerød Hospital
Hillerød, Denmark
Rigshospitalet department of nephrology
København Ø, Denmark
Roskilde Hospital
Roskilde, Denmark
Start Date
November 12, 2019
Primary Completion Date
September 3, 2020
Completion Date
September 3, 2020
Last Updated
September 29, 2020
NCT07396441
NCT06700525
NCT06550297
NCT06420817
NCT06575231
NCT04132128
Lead Sponsor
Rigshospitalet, Denmark
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions